B-cell lymphoma idiotype antigen (None standardized; "Id" or "BCR-idiotype" may be used in literature, but not formally established.)

The B-cell lymphoma idiotype antigen is a patient- and tumor-specific antigen defined by the unique variable region sequence of immunoglobulin expressed on the malignant B cell surface. This idiotype acts as a molecular fingerprint and therapeutic target, enabling highly personalized immunotherapies such as anti-idiotype antibodies and idiotype-based vaccines. Unlike conventional antigens shared among tumors, the idiotype is unique to each patient's B-cell malignancy. Cross-linking the idiotype can trigger direct apoptosis of lymphoma cells or drive targeted immune responses. Challenges include tumor escape through antigen mutation and the need for individualized therapeutic manufacturing.

Other names

Idiotype (Id)Tumor-specific idiotypeBCR idiotypeImmunoglobulin idiotypesIg idiotypeLymphoma idiotype antigen

Direct tumor cell killing via BCR cross-linking and activation-induced cell death; ADCC (antibody-dependent cellular cytotoxicity) and phagocytosis for anti-idiotype antibodies; Induction of tumor-specific immune responses: both T-cell and antibody-mediated (vaccines); Potential for immune memory formation and prevention of relapse (via idiotype vaccines)